In addition, inhibition of purinergic P2X3 receptors on afferent terminals, leading to a decrease in ATP release from the urothelium, can improve the painful sensations in IC/BPS [58]. This evidence concerns the gene P2RX3 and Bartsocas-Papas syndrome 1.